Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurofibromatosis type 1

E Legius1, M J Descheemaeker, J P Fryns

  • 1Center for Human Genetics, University of Leuven, Belgium.

Genetic Counseling (Geneva, Switzerland)
|January 1, 1994
PubMed
Summary

Neurofibromatosis type 1 (NF1) often causes learning disabilities in children. Research shows the NF1 gene acts as a tumor suppressor, with complex oncogenesis requiring specialized care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Risk-reducing mastectomy in BRCA carriers: survival is not the issue.

Breast cancer research and treatment·2019
Same author

Patients with High-Grade Gliomas and Café-au-Lait Macules: Is Neurofibromatosis Type 1 the Only Diagnosis?

AJNR. American journal of neuroradiology·2019
Same author

Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination.

Science (New York, N.Y.)·2018

Area of Science:

  • Genetics
  • Oncology
  • Pediatrics

Background:

  • Neurofibromatosis type 1 (NF1) is a genetic disorder with diverse clinical manifestations.
  • Learning disabilities, including visual-spatial deficits, are common in children with NF1.
  • The NF1 gene, located on chromosome 17, plays a crucial role in disease development.

Purpose of the Study:

  • To review current data on the clinical and molecular aspects of neurofibromatosis type 1.
  • To highlight the association between NF1 and learning disabilities in affected children.
  • To discuss the molecular mechanisms of oncogenesis in NF1 and the gene's tumor suppressor function.

Main Methods:

  • Literature review of clinical and molecular data on NF1.
  • Analysis of genotype-phenotype correlations, noting a general lack thereof.
  • Examination of the NF1 gene's role in tumor suppressor pathways.

Main Results:

  • NF1 is associated with significant learning disabilities and school performance issues in children.
  • The NF1 gene functions as a tumor suppressor, and oncogenesis involves a multi-step process.
  • Limited mutations characterized to date indicate a weak genotype-phenotype correlation.

Conclusions:

  • NF1 management requires specialized multidisciplinary clinics due to its complexity.
  • Understanding the NF1 gene's role is critical for managing associated tumors and developmental issues.
  • Further research is needed to elucidate genotype-phenotype correlations and improve patient outcomes.

Related Experiment Videos